261
© World Health Organization
WHO Technical Report Series, No. 961, 2011
Annex 6
WHO good manufacturing practices for sterile
pharmaceutical products
Introduction
Following implementation of these WHO good manufacturing practices (GMP)
guidelines (
1
) within the context of the WHO Prequalifi cation of Medicines
Programme, clarifying, editorial modifi cations have been proposed. These
changes were adopted for maintenance purposes. In order to ease reading the
full guideline has been reproduced again as an Annex to the current report of
the WHO Expert Committee on Specifi cations for Pharmaceutical Preparations.